- Weaker ISM services reading paradoxically failed to improve sentiment on Wall Street
- Broadcom, Intel and Salesforce lead tech companies' declines
- Sharp drop in iPhone sales in China lifts AAPL shares more than 2.5% lower today
Alphabet broke out below its 200-day exponential moving average. However, the declines were almost fully erased in the second part of the session. Nvidia shares are resisting selling pressure in the semiconductor sector, after CFRA raised its target price for Nvidia to $1,000 per share (previously $840). Today's session appears to be an extension of profit-taking, following Wall Street's impressive rally.
Among technology companies, we see continued weak sentiment around Tesla (TSLA.US) shares. The company's car factory near Berlin was the target of a likely attack by activists who cut its power supply, paralysing production. Sales of iPhones in China fell 24% year-on-year, with the manufacturer overshadowed by market share gainer Huawei, putting a marker over prospects for improving business and valuation multiples.
Start investing today or test a free demo
Open real account TRY DEMO Download mobile app Download mobile app
Shares of BigTech companies are performing mostly poorly today, with Tesla, Microsoft and Apple losing the most heavily. A broader sell-off was halted by Alphabet (GOOGL.US), which, alongside Apple, has long been the weakest company among the 'magnificent seven'. A clear realisation of gains can also be seen among chipmakers, where virtually only Nvidia managed to resist the declines. Source: xStation5
Alphabet (GOOGL.US) shares lost nearly 2% during today's session and temporarily broke out below the support barrier set by the 200-day exponential moving average (golden curve) on the chart. At the moment, however, the magnitude of the declines has been mostly erased, with the company's shares losing "only" 0.35%. Source: xStation
The material on this page does not constitute as financial advice and does not take into account your level of understanding, investment objectives, financial situation or any other particular needs.
All the information provided, including opinions, market research, mathematical results and technical analyses published on the website or transmitted to you by other means is provided for information purposes only and should in no event be interpreted as an offer of, or solicitation for, a transaction in any financial instrument, nor should the information provided be construed as advice of legal or fiscal nature.
Any investment decisions you make shall be based exclusively on your level of understanding, investment objectives, financial situation or any other particular needs. Any decision to act on information published on the website or transmitted to you by other means is entirely at your own risk. You are solely responsible for such decisions.
If you are in doubt or are not sure that you understand a particular product, instrument, service, or transaction, you should seek professional or legal advice before trading.
Investing in OTC Derivatives carries a high degree of risk, as they are leveraged based products and often small movements in the market could lead to much larger movements in the value of your investment and this could work against you or for you. Please ensure that you fully understand the risks involved, taking into account your investments objectives and level of experience, before trading, and if necessary, seek independent advice.
